Author:
Krive Jacob,Shoolin Joel S.,Zink Steven D.
Reference15 articles.
1. A. Qaseem, V. Snow, P. Barry, E.R. Hornbake, J.E. Rodnick, T. Tobolic, B. Ireland, J.B. Segal, E.B. Bass and K.B. Weiss, “Current diagnosis of venous thromboembolism in primary care: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians,” Ann. Intern. Med., vol. 146, pp. 454–458, 2007.
2. F.A. Anderson, H.B. Wheeler, R.J. Goldberg, D.W. Hosmer, N.A. Patwardhan, B. Jovanovic, A. Forcier and J.E. Dalen, “A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study,” Arch. Intern. Med., vol. 151, pp. 933–938, 1991.
3. J.A. Heit, A.T. Cohen and F.A. Anderson Jr, “Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US,” in ASH Annual Meeting Abstracts, pp. 910, 2005.
4. J.A. Heit, W.M. O’Fallon, T.M. Petterson, C.M. Lohse, M.D. Silverstein, D.N. Mohr and L.J. Melton, “Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study,” Arch. Intern. Med., vol. 162, pp. 1245–1248, 2002.
5. C.E. Mahan, M.T. Holdsworth, S.M. Welch, M. Borrego and A.C. Spyropoulos, “Deep-vein thrombosis: a United States cost model for a preventable and costly adverse event,” Thromb. Haemost., vol. 106, pp. 405, 2011.